The Journal of Thrombosis and Thrombolysis is a long-awaited resource for contemporary cardiologists, hematologists, vascular medicine specialists and clinician-scientists actively involved in treatment decisions and clinical investigation of thrombotic disorders involving the cardiovascular and cerebrovascular systems. The principal focus of the Journal centers on the pathobiology of thrombosis and vascular disorders and the use of anticoagulants, platelet antagonists, cell-based therapies and interventions in scientific investigation, clinical-translational research and patient care.

The Journal will publish original work which emphasizes the interface between fundamental scientific principles and clinical investigation, stimulating an interdisciplinary and scholarly dialogue in thrombosis and vascular science. Published works will also define platforms for translational research, drug development, clinical trials and patient-directed applications. The Journal of Thrombosis and Thrombolysis' integrated format will expand the reader's knowledge base and provide important insights for both the investigation and direct clinical application of the most rapidly growing fields in medicine-thrombosis and vascular science.

The Journal seeks original manuscripts devoted to fundamental science in cardiovascular disease, laboratory investigation, pharmacogenetics, clinical research, global health and epidemiology. State-of-the-art reviews, position papers and editorials will be summoned by invitation from the editor or an appointed guest editor. The Journal will publish special issues and supplements from national and international symposia and scientific committees in a timely fashion by working closely with organizers and contributing authors. 94% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again

Journal information

Editor-in-Chief
  • Richard Becker
Publishing model
Hybrid. Open Access options available

Journal metrics

2.054 (2019)
Impact factor
2.123 (2019)
Five year impact factor
29 days
Submission to first decision
65 days
Submission to acceptance
202,674 (2019)
Downloads

Latest articles

Journal updates

  • COVID-19 and impact on peer review

    As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

View all updates

Subscribe

eJournal
$99.00
Note this is only the net price. Taxes will be calculated during checkout.
  • Immediate online access with complete access to all articles
  • Downloadable in PDF format
  • Subscription expires 12/31/2020

About this journal

Electronic ISSN
1573-742X
Print ISSN
0929-5305
Abstracted and indexed in
  1. CNKI
  2. Chemical Abstracts Service (CAS)
  3. Current Contents/Clinical Medicine
  4. EBSCO Biomedical Reference Collection
  5. EMBASE
  6. INIS Atomindex
  7. Japanese Science and Technology Agency (JST)
  8. Journal Citation Reports/Science Edition
  9. Medline
  10. Pathway Studio
  11. ProQuest Biological Science Database
  12. ProQuest Central
  13. ProQuest Health & Medical Collection
  14. ProQuest Health Research Premium Collection
  15. ProQuest Medical Database
  16. ProQuest Natural Science Collection
  17. ProQuest Neurosciences Abstracts
  18. ProQuest Pharma Collection
  19. ProQuest SciTech Premium Collection
  20. Reaxys
  21. SCImago
  22. SCOPUS
  23. Science Citation Index Expanded (SciSearch)
  24. Semantic Scholar
  25. UGC-CARE List (India)
Copyright information

Rights and permissions

Springer policies

© Springer Science+Business Media, LLC, part of Springer Nature